Tatsuya Masuda, Takayoshi Watanabe, Yasutoshi Tatsumi, Jason Lin, Kazuhiro Okumura, Toshinori Ozaki, Hiroshi Sugiyama and Yasuhiko Kamikubo. Cancer accumulation and anti-cancer activity of “CROX (Cluster Regulation of RUNX)” PIP in HER2-positive gastric cancer evaluated by chicken egg cancer model. Cancer Med., in press.

Yasutoshi Tatsumi (筆頭著者), Tatsuya Masuda, Takayoshi Watanabe, Rohmad Yudi Utomo, Ummi Maryam Zulfin, Edy Meiyanto, Toshinori Ozaki, Yusuke Suenaga and Yasuhiko Kamikubo. Anti-tumor effect of Curcumin analogs on osteosarcoma through the inhibition of p300-mediated histone acetylation. Oncol Rep., 53: 47, 2025.

Hideki Yamaguchi, Makoto Miyazaki. Cell biology of cancer peritoneal metastasis: multiclonal seeding and peritoneal tumor microenvironment. Cancer Sci., 2025

Hideki Ikeda, Katsushige Kawase, Tatsuya Nishi, Tomofumi Watanabe, Keizo Takenaga, Takashi Inozume, Takamasa Ishino, Sho Aki, Jason Lin, Shusuke Kawashima, Joji Nagasaki, Youki Ueda, Shinichiro Suzuki, Hideki Makinoshima, Makiko Itami, Yuki Nakamura, Yasutoshi Tatsumi, Yusuke Suenaga, Takao Morinaga, Akiko Honobe-Tabuchi, Takehiro Ohnuma, Tatsuyoshi Kawamura, Yoshiyasu Umeda, Yasuhiro Nakamura, Yukiko Kiniwa, Eiki Ichihara, Hidetoshi Hayashi, Jun-ichiro Ikeda, Toyoyuki Hanazawa, Shinichi Toyooka, Hiroyuki Mano, Takuji Suzuki, Tsuyoshi Osawa, Masahito Kawazu and Yosuke Togashi. Immune Evasion via Mitochondria Transfer in the Tumour Microenvironment. Nature, 638, 225-236, 2025.

Hideki Yamaguchi, Makoto Miyazaki. Heterocellular Adhesion in Cancer Invasion and Metastasis: Interactions between Cancer Cells and Cancer-Associated Fibroblasts. Cancers, 16(9) ; 1636, 2024

Daisuke Hoshi, Emiri Kita, Yoshiaki Maru, Hiroyuki Kogashi, Yuki Nakamura, Yasutoshi Tatsumi, Osamu Shimozato, Kazuyoshi Nakamura, Kentaro Sudo, Akiko Tsujimoto, Ryo Yokoyama, Atsushi Kato, Tetsuo Ushiku, Masashi Fukayama, Makiko Itami, Taketo Yamaguchi and Yoshitaka Hippo. Derivation of pancreatic acinar cell carcinoma cell line HS-1 as a patient-derived tumor organoid. Cancer Sci., 114, 1165-1179, 2023.

Makoto Miyazaki (筆頭著者), Ayaka Nakabo, Yoshiko Nagano, Yuko Nagamura, Kazuyoshi Yanagihara, Rieko Ohki, Yoshikazu Nakamura, Kiyoko Fukami, Jun Kawamoto, Kenji Umayahara, Masaru Sakamoto, Keiichi Iwaya, Hideki Yamaguchi. Tissue factor-induced fibrinogenesis mediates cancer cell clustering and multiclonal peritoneal metastasis. Cancer Lett., 553; 215983, 2023

Yosuke Iwatate, Hajime Yokota, Isamu Hoshino, Fumitaka Ishige, Naoki Kuwayama, Makiko Itami, Yasukuni Mori, Satoshi Chiba, Hidehito Arimitsu, Hiroo Yanagibashi, Wataru Takayama, Takashi Uno, Jason Lin, Yuki Nakamura, Yasutoshi Tatsumi, Osamu Shimozato and Hiroki Nagase. Transcriptomic analysis reveals high ITGB1 expression as a predictor for poor prognosis of pancreatic cancer. PLOS ONE, 17, e0268630-e0268630, 2022.

Yosuke Iwatate, Hajime Yokota, Isamu Hoshino, Fumitaka Ishige, Naoki Kuwayama, Makiko Itami, Yasukuni Mori, Satoshi Chiba, Hidehito Arimitsu, Hiroo Yanagibashi, Wataru Takayama, Takashi Uno, Jason Lin, Yuki Nakamura, Yasutoshi Tatsumi, Osamu Shimozato and Hiroki Nagase. Machine learning with imaging features to predict the expression of ITGAV, which is a poor prognostic factor derived from transcriptome analysis in pancreatic cancer. Int J Oncol., 60, 2022.

Isamu Hoshino, Hajime Yokota, Yosuke Iwatate, Yasukuni Mori, Naoki Kuwayama, Fumitaka Ishige, Makiko Itami, Takashi Uno, Yuki Nakamura, Yasutoshi Tatsumi, Osamu Shimozato and Hiroki Nagase. Prediction of the differences in tumor mutation burden between primary and metastatic lesions by radiogenomics. Cancer Sci., 113, 2022.

Shingo Miyamoto, Yoshiko Nagano, Makoto Miyazaki, Yuko Nagamura, Kazuki Sasaki, Takeshi Kawamura, Kazuyoshi Yanagihara, Toshio Imai, Rieko Ohki, Masakazu Yashiro, Masato Tanaka, Ryuichi Sakai, Hideki Yamaguchi. Integrin α5 mediates cancer cell-fibroblast adhesion and peritoneal dissemination of diffuse-type gastric carcinoma. Cancer Lett., 526; 335-345, 2022

Hideki Yamaguchi, Yuko Nagamura, Makoto Miyazaki. Receptor tyrosine kinases amplified in diffuse-type gastric carcinoma: potential targeted therapies and novel downstream effectors. Cancers, 14; 3750, 2022

Shintaro Iwata, Yasutoshi Tatsumi (責任著者), Tsukasa Yonemoto, Akinobu Araki, Makiko Itami, Hiroto Kamoda, Toshinori Tsukanishi, Yoko Hagiwara, Hideyuki Kinoshita, Takeshi Ishii, Hiroki Nagase and Miki Ohira. CDK4 overexpression is a predictive biomarker for resistance to conventional chemotherapy in patients with osteosarcoma. Oncol Rep., 46: 135, 2021.

Keizo Takenaga, Nobuko Koshikawa, Miho Akimoto, Yasutoshi Tatsumi, Jason Lin, Makiko Itami and Hiroki Nagase. MCT4 is induced by metastasis-enhancing pathogenic mitochondrial NADH dehydrogenase gene mutations and can be a therapeutic target. Sci Rep., 11, 2021.  

Yoshiaki Maru, Naotake Tanaka, Yasutoshi Tatsumi, Yuki Nakamura, Makiko Itami and Yoshitaka Hippo. Kras activation in endometrial organoids drives cellular transformation and epithelial-mesenchymal transition. Oncogenesis, 10, 2021.

Yuko Nagamura, Makoto Miyazaki, Yoshiko Nagano, Arata Tomiyama, Rieko Ohki, Kazuyoshi Yanagihara, Ryuichi Sakai, Hideki Yamaguchi. SHP2 as a potential therapeutic target in diffuse-type gastric carcinoma addicted to receptor tyrosine kinase signaling. Cancers, 13; 4309, 2021

Yuko Nagamura, Makoto Miyazaki, Yoshiko Nagano, Masako Yuki, Kiyoko Fukami, Kazuyoshi Yanagihara, Kazuki Sasaki, Ryuichi Sakai, Hideki Yamaguchi. PLEKHA5 regulates the survival and peritoneal dissemination of diffuse-type gastric carcinoma cells with Met gene amplification. Oncogenesis, 10; 25, 2021

Yoshiko Nakano, Mutsumi Takadera, Makoto Miyazaki, Zhiwei Qiao, Kosei Nakajima, Rei Noguchi, Rieko Oyama, Yui Kimura, Yuki Okuhiro, Kai Yamasaki, Noritsugu Kunihiro, Hiroko Fukushima, Takeshi Inoue, Junichi Hara, Tatsuya Ozawa, Tadashi Kondo, Koichi Ichimura. Drug screening with a novel tumor-derived cell line identified alternative therapeutic options for patients with atypical teratoid/rhabdoid tumor. Human Cell, 34; 271-278, 2021

Tatsuya Kobayashi, Makoto Miyazaki, Nobuyoshi Sasaki, Shun Yamamuro, Eita Uchida, Daisuke Kawauchi, Masamichi Takahashi, Yohei Otsuka, Kosuke Kumagai, Satoru Takeuchi, Terushige Toyooka, Naoki Otani, Kojiro Wada, Yoshitaka Narita, Hideki Yamaguchi, Yoshihiro Muragaki, Takakazu Kawamata, Kentaro Mori, Koichi Ichimura. Arata Tomiyama. Enhanced malignant phenotypes of glioblastoma cells surviving NPe6-mediated photodynamic therapy are regulated via ERK1/2 activation.  Cancers, 12: 3641, 2020

Mohammad Sazzadul Islam, Ryo Takano, Tomoki Yokochi, Jesmin Akter, Yohko Nakamura, Akira Nakagawara, and Yasutoshi Tatsumi (責任著者). Programmed expression of pro-apoptotic BMCC1 during apoptosis, triggered by DNA damage in neuroblastoma cells. BMC Cancer, 19:542, 2019.